Patent application number | Description | Published |
20120327248 | INTEGRATED CIRCUIT FOR SPECTRAL IMAGING SYSTEM - An integrated circuit for an imaging system is disclosed. In one aspect, an integrated circuit has an array of optical sensors, an array of optical filters integrated with the sensors and configured to pass a band of wavelengths onto one or more of the sensors, and read out circuitry to read out pixel values from the sensors to represent an image. Different ones of the optical filters are configured to have a different thickness, to pass different bands of wavelengths by means of interference, and to allow detection of a spectrum of wavelengths. The read out circuitry can enable multiple pixels under one optical filter to be read out in parallel. The thicknesses may vary non monotonically across the array. The read out, or later image processing, may involve selection or interpolation between wavelengths, to carry out spectral sampling or shifting, to compensate for thickness errors. | 12-27-2012 |
20140175265 | Spectral Imaging Device and Method to Calibrate the Same - A solid-state spectral imaging device is described. The device includes an image sensor and a plurality of optical filters directly processed on top of the image sensor. Each optical filter includes a first mirror and a second mirror defining an optical filter cavity having a fixed height. Each optical filter also includes a first electrode and a second electrode having a fixed position located opposite to each other and positioned to measure the height of the optical filter cavity. Further, a method to calibrate spectral data of light and a computer program for calibrating light is described. | 06-26-2014 |
20140267849 | SPECTRAL CAMERA WITH INTEGRATED FILTERS AND MULTIPLE ADJACENT IMAGE COPIES PROJECTED ONTO SENSOR ARRAY - A spectral camera for producing a spectral output is disclosed. The spectral camera has an objective lens for producing an image, an optical duplicator, an array of filters, and a sensor array arranged to detect the filtered image copies simultaneously on different parts of the sensor array. Further, a field stop defines an outline of the image copies projected on the sensor array. The filters are integrated on the sensor array, which has a planar structure without perpendicular physical barriers for preventing cross talk between each of the adjacent optical channels. The field stop enables adjacent image copies to fit together without gaps for such barriers. The integrated filters mean there is no parasitic cavity causing crosstalk between the adjacent image copies. This means there is no longer a need for barriers between adjacent projected image copies, and thus sensor area can be better utilized. | 09-18-2014 |
20140267878 | SPECTRAL CAMERA WITH OVERLAPPING SEGMENTS OF IMAGE COPIES INTERLEAVED ONTO SENSOR ARRAY - A spectral camera having an objective lens, an array of lenses for producing optical copies of segments of the image, an array of filters for the different optical channels and having an interleaved spatial pattern, and a sensor array to detect the copies of the image segments is disclosed. Further, detected segment copies of spatially adjacent optical channels have different passbands and represent overlapping segments of the image, and detected segment copies of the same passband on spatially non-adjacent optical channels represent adjacent segments of the image which fit together. Having segments of the image copied can help enable better optical quality for a given cost. Having an interleaved pattern of the filter bands with overlapping segments enables each point of the image to be sensed at different bands to obtain the spectral output for many bands simultaneously to provide better temporal resolution. | 09-18-2014 |
Patent application number | Description | Published |
20110223377 | LONGITUDINAL BELT WITH REINFORCING FIBRES | 09-15-2011 |
20110283648 | MASONRY WITH STEEL REINFORCEMENT STRIP HAVING SPACERS | 11-24-2011 |
20120090507 | HIGH ELONGATION FIBRES - The invention relates to a steel fibre for reinforcing concrete or mortar. The fibre has a middle portion and two ends. The middle portion has a ensile strength of at least 1000 N and an elongation at maximum load A | 04-19-2012 |
20120097073 | HIGH ELONGATION FIBRE WITH GOOD ANCHORAGE - The invention relates to a steel fibre for reinforcing concrete or mortar. The fibre has a middle portion and anchorage ends. The middle portion has a maximum load capacity F | 04-26-2012 |
20130255540 | STEEL FIBRE FOR REINFORCING CONCRETE OR MORTAR HAVING AN ANCHORAGE END WITH AT LEAST THREE STRAIGHT SECTIONS - A steel fibre for reinforcing concrete or mortar has a middle portion and an anchorage end at one or both ends of the middle portion. The middle portion has a main axis. The anchorage end comprises at least a first straight section, a first bent section, a second straight section, a second bent section and a third straight section. The first straight section and the third straight section are bending away from the main axis of the middle portion in the same direction. The second straight section is substantially parallel with the main axis of said middle portion. | 10-03-2013 |
20130269572 | STEEL FIBRE FOR REINFORCING CONCRETE OR MORTAR HAVING AN ANCHORAGE END WITH AT LEAST TWO BENT SECTIONS - A steel fibre for reinforcing concrete or mortar comprises a middle portion and an anchorage end at one or both ends of the middle portion. The middle portion has a main axis. The anchorage end is deflecting from the main axis of the middle portion in a deflection section. The anchorage end has n bent sections, with n equal or larger than 2. The steel fibre is configured so that when the steel fibre is in a stable position on a horizontal surface being vertically projected on this horizontal surface, the vertical projections in this horizontal surface of all of the n bent sections of an anchorage end are located at one side of the vertical projection in this horizontal surface of the main axis of the middle portion. | 10-17-2013 |
Patent application number | Description | Published |
20120195858 | RESPONSIVENESS TO ANGIOGENESIS INHIBITORS - The present invention relates to methods for improving the overall survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the vascular endothelial growth factor receptor 1 (VEGFR-1) gene. The present invention further provides methods for improving the progression-free survival of a patient suffering from a malignant disease or a disease involving physiological and pathological angiogenesis by treatment with an angiogenesis inhibitor, such as bevacizumab, by determining the presence of one or more variant alleles of the VEGFR-1 gene. The present invention also provides for methods for assessing the responsiveness of a patient to an angiogenesis inhibitor by determining the presence of one or more variant alleles of the VEGFR-1 gene. | 08-02-2012 |
20140294768 | RESPONSIVENESS TO ANGIOGENESIS INHIBITORS - The invention is concerned with a method of determining whether a patient is more suitably treated by a therapy with an angiogenesis inhibitor, such as bevacizumab, by determining the genotype of VEGF promoter gene and/or VEGFR2 gene. The invention further relates to a pharmaceutical composition comprising an angiogenesis inhibitor, such as bevacizumab, for the treatment of a patient suffering from cancer based on the genotype of VEGF promoter gene and/or VEGFR2 gene. The invention further relates to a method for improving the treatment effect of chemotherapy of a patient suffering from cancer by adding an angiogenesis inhibitor, such as bevacizumab, based on the genotype of VEGF promoter gene and/or VEGFR2 gene. | 10-02-2014 |
20140294811 | METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY - The invention is concerned with a method of predicting a patient's susceptibility to developing hypertension associated with an anti-angiogenesis treatment, such as bevacizumab, by determining the genotype of KDR gene and/or EGF gene. The invention further relates to a pharmaceutical composition comprising an angiogenesis inhibitor, such as bevacizumab, for the treatment of a patient suffering from cancer based on the genotype of KDR gene and/or EGF. The invention further relates to a method for reducing the risk of hypertension associated with an anti-angiogenesis therapy, such as bevacizumab, in a patient suffering from cancer by determining the genotype of KDR gene and/or EGF gene. | 10-02-2014 |